News Release

Grant of £20 million to establish the Schistosomiasis Control Initiative

Project to give hope to developing countries

Grant and Award Announcement

Imperial College London

Imperial College London today announced that the Bill & Melinda Gates Foundation has given a grant of $30 million (£20 million) to establish the Schistosomiasis Control Initiative (SCI), a partnership at Imperial College London including the foundation, the World Health Organization and the Harvard School of Public Health.

Schistosomiasis is a parasitic disease that leads to chronic ill-health and affects more than 200 million people in developing countries. Approximately 600 million people are at risk of contracting schistosomiasis because they live in tropical regions where water supply and sanitation are inadequate or non-existent.

The primary goals of the SCI are to identify the most heavily infected regions in at least four African countries, provide health education to the people in those regions, treat victims of schistosomiasis and monitor the impact of the treatment program. By demonstrating that more effective control of schistosomiasis can be achieved in the selected countries, the initiative will provide a model that can be emulated in other countries affected by this disease.

The SCI will develop local and international partnerships to improve training and treatment delivery, and to assist other African nations in the development of national control plans and research programs. The SCI will also work with existing organizations to improve the delivery of the treatment. For example, it will add an annual drug treatment to the food deliveries provided by the World Food Program, an organization that reaches several million children.

Dr Alan Fenwick, Director of the Schistosomiasis Control Initiative, comments: "The misery and ill health caused by schistosomiasis is so unnecessary. There is a drug, praziquantel, that is safe, effective, and reasonably priced. The challenge now is to deliver this treatment to places like sub-Saharan Africa where the drug has never been available. This grant will help us make that possible."

"Stopping the spread of infectious disease is a key priority for the foundation," said Sally Stansfield, M.D., Acting Director of Infectious Disease and Vaccines Program for the Bill & Melinda Gates Foundation. "By creating a successful prevention and treatment program that can be emulated in countries around the world, SCI has the opportunity to make a major impact in the fight against schistosomiasis."

Sir Richard Sykes, Rector of Imperial College London, adds: "This is a very exciting opportunity for Imperial College to work with the Bill & Melinda Gates Foundation, WHO, and Harvard University to play a part in attempting to alleviate the enormous burden of suffering and death caused by infectious disease in Africa. The implementation of the Schistosomiasis Control Initiative and the complementary research program fits neatly into Imperial College's expanding portfolio of medical research programs in international health."

John Hutton, English Health Minister, adds: "I am delighted that Imperial College have been granted this award of £20 million from the Bill and Melinda Gates Foundation. Advances in medical research are crucial to the NHS, for both patients and staff. This is an extremely worthwhile project that is vital to the health of millions of people in developing countries, as well as a fantastic opportunity for the College, which contributes invaluably to the work of the World Health Organisation."

Schistosomiasis

Schistosomiasis is a worm parasite which currently affects over 200 million people in the tropics, where water supply and sanitation are inadequate or non-existent.

The microscopic parasite, which multiplies in fresh water snails, enters the human body through the skin, when people come into contact with fresh water.

After entering the body, the parasite travels to the liver, where it grows to a worm about a centimeter in length. Male and female worms pair up and then live for many years in the blood vessels around the bladder and intestine, feeding off the blood. Female worms lay many eggs, which escape from the body back to the water during urination and defecation.

In heavy infections, thousands of eggs escape from the body daily, but do so by rupturing capillary blood vessels causing heavy blood loss. Those eggs which do not escape become trapped in the liver, causing a blockage and extreme damage, eventually leading to death.

Those most at risk of schistosomiasis are school-age children, women, and those involved in occupations such as irrigation farming and fishing.

###

For more information, please contact:

Tony Stephenson
Imperial College Press Office
Tel: +44 (0)20 7594 6712
Mobile: +44 07753 739766
E-mail: at.stephenson@ic.ac.uk

Jenny Sorensen
Bill & Melinda Gates Foundation
Phone: +1 425.467-0114
Email: media@gatesfoundation.org

Notes to editors:

1. In May 2001, the World Health Assembly passed a resolution that treatment for schistosomiasis and intestinal helminths in all member states in infected regions should reach 75 per cent of all school aged children by the year 2010. The Schistosomiasis Control Initiative aims to assist in the implementation of this resolution within Africa.

2. Consistently rated in the top three UK university institutions, Imperial College London is a world leading science-based university whose reputation for excellence in teaching and research attracts students (10,000) and staff (5,000) of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions that enhance the quality of life and the environment - underpinned by a dynamic enterprise culture. Website: www.ic.ac.uk.

3. The Bill & Melinda Gates Foundation is dedicated to improving people's lives by sharing advances in health and learning with the global community. Led by Bill Gates' father, William H. Gates, Sr., and Patty Stonesifer, the Seattle-based foundation has an endowment of approximately $24 billion. www.gatesfoundation.org

4. The unit will be based in the Department of Infectious Disease Epidemiology, next to St Mary's Hospital. The Head of the Department of Infectious Disease Epidemiology is Professor Roy Anderson FRS, and the Director of the Schistosomiasis Control Initiative (SCI) is Dr Alan Fenwick OBE, who has recently returned to the UK after working in Tanzania, Sudan and Egypt for many years. Co-author of the grant application was Professor Michael Reich at the Harvard School of Public Health in Boston. Professor Reich will direct a schistosomiasis research project for the SCI at the Harvard Centre for Population and Development Studies in Cambridge, Massachusetts.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.